Press release
Sarcopenia Market to Grow at 4.30% CAGR Through 2034
Sarcopenia Market Share
The sarcopenia market is segmented by treatment type, route of administration, end user, and distribution channel. Among treatments, protein supplements and pharmacotherapy are gaining prominence due to their established roles in muscle mass enhancement and function preservation.
From a geographic perspective, North America dominates due to a higher aging population, well-developed healthcare infrastructure, and the presence of global market leaders such as AbbVie Inc., Amgen Inc., and Pfizer Inc.. Meanwhile, Japan and the EU-4 (Germany, France, Italy, Spain) represent significant secondary markets due to increasing healthcare spending and rising awareness of sarcopenia as a clinical condition.
Get a Free Sample Report with Table of Contents - https://bitl.to/4kmr.
Sarcopenia Market Growth & Trends
Several drivers are fueling the sarcopenia market's growth trajectory:
Aging Demographics: A growing elderly population globally-particularly in developed regions-is leading to higher incidences of age-associated muscle degeneration.
Clinical Recognition of Sarcopenia: Once overlooked, sarcopenia is now increasingly recognized as a treatable medical condition. This shift is accelerating diagnosis and treatment efforts.
Nutritional Interventions: The rise of functional foods and nutraceuticals, especially those targeting muscle health, is reinforcing the need for non-pharmacologic treatment options.
Advancements in Biomarkers and Diagnostics: New diagnostic technologies for assessing muscle mass and function are enabling earlier intervention.
Preventive Healthcare Focus: The broader shift toward preventive healthcare is encouraging investments in sarcopenia screening and management programs.
Sarcopenia Market Case Studies & News
Recent industry developments showcase ongoing innovation:
In 2023, Nestlé Health Science launched a new muscle health supplement combining vitamin D, whey protein, and leucine, targeting elderly patients with early-stage sarcopenia.
Amgen Inc. partnered with biotech startups to investigate the myostatin inhibitor class of drugs aimed at increasing muscle mass.
Clinical trials in Europe and Japan are testing the efficacy of combination therapies (nutrition + pharmacotherapy) for elderly individuals showing early signs of muscle atrophy.
These developments highlight the increasing attention the condition is receiving from both pharmaceutical and nutritional science domains.
Read the Full Report with the Table of Contents - https://bitl.to/4kmq.
Sarcopenia Market Analysis
The sarcopenia market is relatively fragmented, with a mix of pharmaceutical giants, nutraceutical firms, and biotech innovators competing to address a growing patient base.
Regulatory Developments: Many countries are introducing guidelines for the clinical identification and management of sarcopenia. For example, the European Working Group on Sarcopenia in Older People (EWGSOP) has issued criteria that guide diagnosis and care strategies.
Market Dynamics: Companies that combine therapeutics with nutritional solutions are well-positioned for growth. In parallel, digital health tools are being explored for remote monitoring and early diagnosis, especially in home care settings.
To learn more about the condition and its implications, see Wikipedia's article on sarcopenia.
Sarcopenia Market Segmentation
Market Breakup by Treatment Type:
Protein Supplement - Helps boost muscle synthesis and counteract muscle loss.
Vitamin B12 Supplement - Targets common deficiencies in older adults.
Vitamin D & Calcium Supplement - Supports bone integrity and muscle function.
Pharmacotherapy - Involves prescription drugs targeting muscle mass and strength.
Others
Market Breakup by Route of Administration:
Oral - Most common and patient-friendly method.
Parenteral - Used for rapid or direct absorption via injections.
Others
Market Breakup by End User:
Hospitals - Provide inpatient diagnosis and care.
Homecare - Expanding with aging-in-place trends and remote health tools.
Specialty Clinics - Focused care centers for geriatrics or muscle disorders.
Others
Market Breakup by Distribution Channel:
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Others
Market Breakup by Region:
United States
EU-4 and the United Kingdom
Germany
France
Italy
Spain
United Kingdom
Japan
China
The United States and Japan lead the market owing to their high elderly populations and proactive geriatric healthcare programs. Europe follows closely, with ongoing awareness campaigns and supportive regulatory frameworks.
Sarcopenia Market Key Players
Prominent companies in the sarcopenia market include:
Amgen Inc.
F-Hoffmann La-Roche
American Way (Amway) Corporation
Abbott Laboratories, Inc.
AbbVie Inc.
Merck Sharp & Dohme Corp.
AstaReal AB
Pfizer Inc.
Sanofi S.A.
Nestlé Health Science
Zydus Cadila
Bayer AG
Johnson & Johnson
Novartis AG
These players are actively investing in R&D, product expansion, and strategic collaborations to gain a competitive edge in a growing yet underdiagnosed market.
Access More Reports
United States Medical Adhesives Market - https://linkd.so/3CtO.
Sjogren's Syndrome Therapeutics Market - https://linkd.so/3CtP.
Peripheral Artery Disease Market - https://linkd.so/3CtQ.
Major Depressive Disorder Treatment Market - https://linkd.so/3CtR.
Media Contact
Company Name: Claight Corporation
Contact Person: Roshan Kumar, Business Consultant
Email: sales@expertmarketresearch.com
Toll-Free Number: US +1-415-325-5166 | UK +44-702-402-5790
Address: 30 North Gould Street, Sheridan, WY 82801, USA
Website: www.expertmarketresearch.com
About Us
Acquire unparalleled access to critical industry insights with our comprehensive market research reports, meticulously prepared by a team of seasoned experts. These reports are designed to equip decision-makers with an in-depth understanding of prevailing market trends, competitive landscapes, and growth opportunities.
Our high-quality, data-driven analysis provides the essential framework for organizations seeking to make informed and strategic decisions in an increasingly complex and rapidly evolving business environment. By investing in our market research reports, you can ensure your organization remains agile, proactive, and poised for success in today's competitive market.
Don't miss the opportunity to elevate your business intelligence and strengthen your strategic planning. Secure your organization's future success by acquiring one of our Expert Market Research reports today.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Sarcopenia Market to Grow at 4.30% CAGR Through 2034 here
News-ID: 4081356 • Views: …
More Releases from Expert Market Research
United States Webcam Market Size, Growth & Trends 2025-2034
The United States webcam market has experienced substantial growth in recent years, fueled by the increasing demand for high-quality video communication tools. Webcams, which were once primarily used for video conferencing, have become essential for various applications, including content creation, gaming, online education, and telehealth. The widespread adoption of remote work and digital learning has further accelerated the growth of this market.
In 2024, the U.S. webcam market was valued at…
Precision Medicine Market: A Deep Dive into Its Evolving Landscape
The precision medicine market represents one of the most transformative shifts in modern healthcare. Instead of relying on generalized treatments that assume all patients respond similarly, precision medicine leverages biological, genetic, and lifestyle data to deliver interventions tailored to the individual. This personalized approach is reshaping how diseases are prevented, diagnosed, and managed. Its importance continues to grow as healthcare systems seek more efficient, patient-centered solutions capable of improving outcomes…
Global Industrial Hemp Market: Growth, Trends, and Future Outlook 2034
The global industrial hemp market is on a rapid growth trajectory. In 2024, the market size is expected to reach approximately USD 5.99 billion, and it's projected to grow at a compound annual growth rate (CAGR) of 19.00% during the forecast period from 2025 to 2034. By 2034, the market is set to reach an impressive value of USD 34.16 billion. This growth is driven by the increasing demand for…
Laboratory Information System Market Hits $2.1B, 9% CAGR
Why Is the Laboratory Information System Market Growing So Rapidly in 2024-2034?
The laboratory information system market is undergoing significant expansion due to increasing digitalization in healthcare and growing demand for efficient diagnostic workflow management. As laboratories face rising testing volumes, stricter regulatory requirements, and a growing need for automated sample tracking, the adoption of LIS platforms has accelerated globally.
In 2024, the market reached USD 2.10 Billion, and with a robust…
More Releases for Sarcopenia
Key Factor Supporting Global Sarcopenia Treatment Market Development in 2025: Su …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Sarcopenia Treatment Market Size By 2025?
The market dedicated to sarcopenia treatments has witnessed robust expansion over the past few years, projected to escalate from a valuation of $3.52 billion in 2024 to $3.72 billion a year later, reflecting a compound annual growth rate of…
Sarcopenia Market Size, Share & Growth Analysis 2034
Sarcopenia Market Overview
Sarcopenia is a condition characterized by the progressive loss of muscle mass, strength, and function, primarily affecting the elderly. This decline leads to increased frailty, higher risk of falls, and diminished quality of life. The rising global geriatric population has heightened the prevalence of sarcopenia, making it a significant public health concern. Consequently, there is a growing demand for effective treatments and interventions to manage and mitigate the…
Sarcopenia Treatment Market Report 2024 - Sarcopenia Treatment Market Size And G …
"The Business Research Company recently released a comprehensive report on the Global Sarcopenia Treatment Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.
According to The Business Research Company's, The sarcopenia treatment market…
Sarcopenia Pipeline Insights Report 2023 (Updated)
(Albany, United States) As per DelveInsight's assessment, globally, the Sarcopenia Pipeline constitutes 8+ key companies continuously working towards developing 10+ Sarcopenia Pipeline treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analysis DelveInsight.
In the Sarcopenia Pipeline Report, a detailed description of the drug is given which includes the mechanism of action of the drug, clinical studies, Sarcopenia NDA approvals (if any), and product…
Global Sarcopenia Therapeutic Market Research Report 2023
The global Sarcopenia Therapeutic market was valued at US$ 2867.6 million in 2022 and is anticipated to reach US$ 3484.4 million by 2029, witnessing a CAGR of 3.3% during the forecast period 2023-2029.
view full report
https://reports.valuates.com/market-reports/QYRE-Auto-13K14453/global-sarcopenia-therapeutic
Sarcopenia Therapeutic Market
Sarcopenia is a syndrome caused by continuous loss of skeletal muscle mass, strength, and function.
The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
China is the largest consumption region of…
Sarcopenia - Drug Pipeline Landscape, 2022
Sarcopenia is a condition characterized by the loss of muscle mass and strength. It can occur due to a variety of reasons, including aging, inactivity, and certain chronic diseases.
Aging is the most common cause of sarcopenia. As people age, they tend to become less active and lose muscle mass. This process is known as age-related muscle loss or sarcopenia with aging.
Inactivity can also lead to sarcopenia. People who are not…
